InvestorsHub Logo

yeababy39

09/19/13 5:40 PM

#63923 RE: Frankinjohn74 #63922

looks like mmrf is turning the corner to the upside. shareholders will benefit while the people not in the game will leave with a wimper. Time is on our side !!!!

croptop

09/19/13 7:22 PM

#63924 RE: Frankinjohn74 #63922

Hmmmmm
Was Europe ahead of USA?
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2013/03/human_orphan_001170.jsp&mid=WC0b01ac058001d12b

On 24 January 2013, orphan designation (EU/3/12/1097) was granted by the European Commission to Celgene Europe Limited, United Kingdom, for lenalidomide for the treatment of follicular lymphoma.



Great for Celgene!!!

MMRF is not a love child.. No such thing as "loyalty" to a stock, a CEO, or a Company, especially a OTC, its an investment, and only good for a return of $$$$....Keep real
JMHO